+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis A, Hepatitis B, Hepatitis C), Technology (Enzyme-Linked Immunosorbent Assay, Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction), End-User - Forecast 2024-2030- Product Image
Global Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis A, Hepatitis B, Hepatitis C), Technology (Enzyme-Linked Immunosorbent Assay, Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction), End-User - Forecast 2024-2030- Product Image
Sale

Global Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis A, Hepatitis B, Hepatitis C), Technology (Enzyme-Linked Immunosorbent Assay, Isothermal Nucleic Acid Amplification Technology, Polymerase Chain Reaction), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4904514
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Hepatitis Test Solution/Diagnosis Market size was estimated at USD 3.53 billion in 2023, USD 3.71 billion in 2024, and is expected to grow at a CAGR of 5.48% to reach USD 5.13 billion by 2030.

The hepatitis test solutions/ diagnosis are used to diagnose the hepatitis virus depending on the type of hepatitis infection. The prevalence of hepatitis is increasing, creating a need for more efficient and reliable diagnosis and testing solutions. Early detection and diagnosis of hepatitis disease are critical to successfully treat patients with improved outcomes. Thus, the vendors are focusing on developing new testing solutions that allow healthcare providers to detect the presence of the virus more accurately, allowing for better treatment outcomes and improved patient care. Moreover, government and non-profit organizations are taking necessary measures to increase awareness about hepatitis to reduce the risk by providing information about symptoms and prevention measures, encouraging regular testing, and improving access to medical facilities for diagnosis and treatment. However, high costs associated with hepatitis test solutions with the issues of inaccurate test results limit product penetration in the market. The ongoing advancements and growing penetration of point-of-care testing options are expected to augment the need for hepatitis test solutions/ diagnosis in the coming years.

Regional Insights

The hepatitis test solutions/diagnosis market in the Americas is rapidly proliferating owing to the increasing prevalence of hepatitis, ongoing awareness among the population, and advancements in testing and diagnosis procedures. As per the PAHO, there are 10,000 new hepatitis B infections each year in the Americas. The EMEA region observes an evolving hepatitis test solutions/diagnosis market due to supportive government policies to eliminate hepatitis B and C from the European economies, with the majority presence of pharmaceutical vendors making efforts to expand their hepatitis test solutions/diagnosis product portfolios. The ongoing awareness campaigns to overcome the burden of hepatitis prevalence in the Asian region and the growing presence of point-of-care testing facilities are anticipated to propel the need for hepatitis test solutions/diagnosis in the coming years.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hepatitis Test Solution/Diagnosis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hepatitis Test Solution/Diagnosis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hepatitis Test Solution/Diagnosis Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Avantor Inc., Beckman Coulter, Inc., Bio-Rad Laboratories Inc., bioMérieux SA, Cepheid, Creative Diagnostics, DiaSorin S.p.A., Epitope Diagnostics, Inc., Everlywell, Inc., F. Hoffmann-La Roche AG, FUJIREBIO Inc., GenMark Diagnostics, Inc., Grifols S.A., Hologic, Inc., Laboratory Corporation of America Holdings, MedMira Inc., Merck & Co., Inc, Meridian Bioscience, Inc., OraSure Technologies, Inc., Ortho Clinical Diagnostics, Prometheus Laboratories, QIAGEN GmbH, Quest Diagnostics Incorporated, Randox Laboratories, Sanofi S.A., Siemens AG, Thermo Fisher Scientific Inc., Vela Diagnostics, and Werfen, S.A.

Market Segmentation & Coverage

This research report categorizes the Hepatitis Test Solution/Diagnosis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Disease Type
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
  • Technology
    • Enzyme-Linked Immunosorbent Assay
    • Isothermal Nucleic Acid Amplification Technology
    • Polymerase Chain Reaction
    • Rapid Diagnostic Tests
  • End-User
    • Blood Banks
    • Diagnostic Laboratories
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Hepatitis Test Solution/Diagnosis Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hepatitis Test Solution/Diagnosis Market?
  3. What are the technology trends and regulatory frameworks in the Hepatitis Test Solution/Diagnosis Market?
  4. What is the market share of the leading vendors in the Hepatitis Test Solution/Diagnosis Market?
  5. Which modes and strategic moves are suitable for entering the Hepatitis Test Solution/Diagnosis Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Hepatitis Test Solution/Diagnosis Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of hepatitis worldwide
5.1.1.2. Need for earlier detection and diagnosis of diseases
5.1.1.3. Increasing awareness about hepatitis by government and non-profit organizations
5.1.2. Restraints
5.1.2.1. High cost associated with tests and diagnosis of hepatitis
5.1.3. Opportunities
5.1.3.1. Advances in viral hepatitis testing and diagnosis
5.1.3.2. Introduction of point-of-care testing options
5.1.4. Challenges
5.1.4.1. Concerns associated with inaccurate test results
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Hepatitis Test Solution/Diagnosis Market, by Disease Type
6.1. Introduction
6.2. Hepatitis A
6.3. Hepatitis B
6.4. Hepatitis C
7. Hepatitis Test Solution/Diagnosis Market, by Technology
7.1. Introduction
7.2. Enzyme-Linked Immunosorbent Assay
7.3. Isothermal Nucleic Acid Amplification Technology
7.4. Polymerase Chain Reaction
7.5. Rapid Diagnostic Tests
8. Hepatitis Test Solution/Diagnosis Market, by End-User
8.1. Introduction
8.2. Blood Banks
8.3. Diagnostic Laboratories
8.4. Hospitals
9. Americas Hepatitis Test Solution/Diagnosis Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hepatitis Test Solution/Diagnosis Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Hepatitis Test Solution/Diagnosis Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Agreement, Collaboration, & Partnership
12.3.1.1. DOH Partners with Local Laboratories to Expand Testing for Curable Hepatitis C
12.3.2. New Product Launch & Enhancement
12.3.2.1. Sanofi Announces Launch of AVAXIM Junior in the UK for Active Immunization Against Infection Caused by the Hepatitis A Virus in Children Aged 12 Months to 15 Years
12.3.2.2. Roche Launches Dual Antibody, Antigen Hepatitis C Virus Diagnostic Test
12.3.2.3. Abbott launches solution to detect Hepatitis B virus
12.3.3. Investment & Funding
12.3.3.1. Unitaid Makes USD 31 Million Investment in Harm Reduction Efforts to Prevent Hepatitis C Among People who Inject Drugs and Others at High Risk
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. AbbVie Inc.
13.1.3. Avantor Inc.
13.1.4. Beckman Coulter, Inc.
13.1.5. Bio-Rad Laboratories Inc.
13.1.6. bioMérieux SA
13.1.7. Cepheid
13.1.8. Creative Diagnostics
13.1.9. DiaSorin S.p.A.
13.1.10. Epitope Diagnostics, Inc.
13.1.11. Everlywell, Inc.
13.1.12. F. Hoffmann-La Roche AG
13.1.13. FUJIREBIO Inc.
13.1.14. GenMark Diagnostics, Inc.
13.1.15. Grifols S.A.
13.1.16. Hologic, Inc.
13.1.17. Laboratory Corporation of America Holdings
13.1.18. MedMira Inc.
13.1.19. Merck & Co., Inc
13.1.20. Meridian Bioscience, Inc.
13.1.21. OraSure Technologies, Inc.
13.1.22. Ortho Clinical Diagnostics
13.1.23. Prometheus Laboratories
13.1.24. QIAGEN GmbH
13.1.25. Quest Diagnostics Incorporated
13.1.26. Randox Laboratories
13.1.27. Sanofi S.A.
13.1.28. Siemens AG
13.1.29. Thermo Fisher Scientific Inc.
13.1.30. Vela Diagnostics
13.1.31. Werfen, S.A.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET RESEARCH PROCESS
FIGURE 2. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2023 VS 2030
FIGURE 3. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET DYNAMICS
FIGURE 7. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 8. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 6. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS A, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS C, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 10. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 15. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 33. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. CHINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. CHINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. INDIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. INDIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. JAPAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. JAPAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. THAILAND HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. THAILAND HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. EGYPT HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. EGYPT HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. FINLAND HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. FINLAND HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. NORWAY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. NORWAY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. POLAND HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. POLAND HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. QATAR HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. QATAR HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. TURKEY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. TURKEY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 146. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Avantor Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • bioMérieux SA
  • Cepheid
  • Creative Diagnostics
  • DiaSorin S.p.A.
  • Epitope Diagnostics, Inc.
  • Everlywell, Inc.
  • F. Hoffmann-La Roche AG
  • FUJIREBIO Inc.
  • GenMark Diagnostics, Inc.
  • Grifols S.A.
  • Hologic, Inc.
  • Laboratory Corporation of America Holdings
  • MedMira Inc.
  • Merck & Co., Inc
  • Meridian Bioscience, Inc.
  • OraSure Technologies, Inc.
  • Ortho Clinical Diagnostics
  • Prometheus Laboratories
  • QIAGEN GmbH
  • Quest Diagnostics Incorporated
  • Randox Laboratories
  • Sanofi S.A.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Vela Diagnostics
  • Werfen, S.A.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.71 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.13 Billion
Compound Annual Growth Rate5.4%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Hepatitis E Diagnostic Tests Market Size, Share & Trends Analysis Report By Type (ELISA HEV IgM Test, Rapid Diagnostics Test), By End Use (Hospitals, Blood Banks), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Hepatitis E Diagnostic Tests Market Size, Share & Trends Analysis Report By Type (ELISA HEV IgM Test, Rapid Diagnostics Test), By End Use (Hospitals, Blood Banks), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Hepatitis Test Solution/Diagnosis - Global Strategic Business Report - Product Image

Hepatitis Test Solution/Diagnosis - Global Strategic Business Report

  • Report
  • 88 Pages
  • Global
From
Global Hepatitis Diagnostic Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Global Hepatitis Diagnostic Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 110 Pages
  • Global
From
Hepatitis Diagnostic Tests Market Report by Test Type (Blood Tests, Imaging Test, Liver Biopsy), and Region 2024-2032 - Product Image

Hepatitis Diagnostic Tests Market Report by Test Type (Blood Tests, Imaging Test, Liver Biopsy), and Region 2024-2032

  • Report
  • 149 Pages
  • Global
From
Global Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Forecast to 2028 - Product Image

Global Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Forecast to 2028

  • Report
  • 303 Pages
  • Global
From

About the Hepatitis Test Solution Diagnosis Market

In the realm of infectious disease testing, the hepatitis test solution diagnosis market comprises a segment focused on detecting and quantifying the presence of hepatitis infections, which include Hepatitis A, B, C, D, and E. Diagnosis of these conditions is critical due to their impact on liver function and potential for causing liver disease, cirrhosis, or carcinoma. The market includes a variety of testing modalities such as immunoassay-based tests, PCR-based tests, and point-of-care testing platforms. These diagnostic tools help in screening blood donations, monitoring the disease, and managing treatment regimens for infected patients. Advances in biotechnology have led to the development of more rapid and sensitive tests, facilitating early detection and improved patient outcomes. Numerous enterprises partake in the hepatitis test solution diagnosis market. Some notable companies include Abbott Laboratories, known for their range of immunoassays and laboratory equipment; Roche Diagnostics, offering advanced molecular assays; Siemens Healthineers, providing a comprehensive suite of diagnostic solutions; and QIAGEN, which supplies technologies for nucleic acid amplification testing. Additionally, Bio-Rad Laboratories and Beckman Coulter offer a variety of testing reagents and instruments that support hepatitis diagnosis. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.